Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sierra

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Salud Publica De Mexico|December 7, 2023
Loretto J Carvajal, Rolando Herrero, María M Angulo, et al.
The Lancet. Infectious Diseases|July 19, 2025
Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9-14 years compared with three doses of quadrivalent HPV vaccine in women aged 18-25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trialBernal Cortés, Rebeca Ocampo, Carolina Porras, et al.
NPJ Vaccines|March 30, 2022
HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trialSabrina H Tsang, John T Schiller, Carolina Porras, et al.
Preventive Medicine Reports|August 14, 2023
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshopAnne E Schuind, Helen Rees, John Schiller, et al.
Journal of the National Cancer Institute|February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT TrialAimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.
The New England Journal of Medicine|December 3, 2025
Noninferiority of One HPV Vaccine Dose to Two DosesAimée R Kreimer, Carolina Porras, Danping Liu, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
Pediatric Pulmonology|April 18, 2026
Exocrine Pancreatic Function in Pediatric Patients After Two Years of Triple CFTR Modulator Therapy: Is It Possible to Restore Pancreatic Function?C M López Cárdenes, S Vicente Santamaría, R García Romero, et al.
Pediatric Pulmonology|September 24, 2024
Effects on growth, weight and body composition after CFTR modulators in children with cystic fibrosisC M López Cárdenes, A Merino Sánchez-Cañete, S Vicente Santamaría, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Salud Publica De Mexico|December 7, 2023
Loretto J Carvajal, Rolando Herrero, María M Angulo, et al.
The Lancet. Infectious Diseases|July 19, 2025
Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9-14 years compared with three doses of quadrivalent HPV vaccine in women aged 18-25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trialBernal Cortés, Rebeca Ocampo, Carolina Porras, et al.
NPJ Vaccines|March 30, 2022
HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trialSabrina H Tsang, John T Schiller, Carolina Porras, et al.
Preventive Medicine Reports|August 14, 2023
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshopAnne E Schuind, Helen Rees, John Schiller, et al.
Journal of the National Cancer Institute|February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT TrialAimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.
The New England Journal of Medicine|December 3, 2025
Noninferiority of One HPV Vaccine Dose to Two DosesAimée R Kreimer, Carolina Porras, Danping Liu, et al.
Vaccine|December 3, 2021
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trialCarolina Porras, Joshua N Sampson, Rolando Herrero, et al.
Pediatric Pulmonology|April 18, 2026
Exocrine Pancreatic Function in Pediatric Patients After Two Years of Triple CFTR Modulator Therapy: Is It Possible to Restore Pancreatic Function?C M López Cárdenes, S Vicente Santamaría, R García Romero, et al.
Pediatric Pulmonology|September 24, 2024
Effects on growth, weight and body composition after CFTR modulators in children with cystic fibrosisC M López Cárdenes, A Merino Sánchez-Cañete, S Vicente Santamaría, et al.
Pageof 9